Levamisole can modulate the serum tumor necrosis factor-α level in patients with recurrent aphthous ulcerations

Journal of Oral Pathology and Medicine

Volumn 35, Issue 2, 2006, Pages 111-116

  Sun, Andy ^a,b   Wang, Jeng Tzung ^a,b   Chia, Jean San ^a,b   Chiang, Chun Pin ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Levamisole; Recurrent aphthous ulcerations; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LEVAMISOLE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APHTHOUS ULCER; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOST RESISTANCE; HUMAN; INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STAGING;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; LEVAMISOLE; MALE; MIDDLE AGED; MOUTH MUCOSA; ORAL ULCER; RECURRENCE; STOMATITIS, APHTHOUS; STOMATITIS, HERPETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645219921     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00383.x     Document Type: Article

References (28)

1. Sun A Wu YC Kwan HW. Immunological aspects of recurrent oral ulcers: serum immunoglobulins, complements and antinuclear factor Chin Dent J 1983 2 28 32
2. Sun A Wu YC Liang LC Kwan HW. Circulating immune complexes in recurrent oral ulcers J Dermatol 1986 13 170 4
3. Sun A Wu YC Hsieh RP Kwan HW Lu YC. Changes of T-lymphocyte subset in recurrent aphthous ulcers J Formos Med Assoc 1987 86 718 22
4. Savage NW Seymour GJ Kruger BJ. T-lymphocyte subset changes in recurrent aphthous stomatitis Oral Surg Oral Med Oral Pathol 1985 60 175 81
5. Savage NW Mahanonda R Seymour GJ Bryson GJ Collins RJ. The proportion of suppressor-inducer T-lymphocytes is reduced in recurrent aphthous stomatitis J Oral Pathol 1988 17 293 7
6. Pedersen A Klausen B Hougen HP Stenvang JP. T-lymphocyte subsets in recurrent aphthous ulceration J Oral Pathol Med 1989 18 59 60
7. Landesberg R Fallon M Insel R. Alterations of T helper/inducer and T suppressor/inducer cells in patients with recurrent aphthous ulcers Oral Surg Oral Med Oral Pathol 1990 69 205 8
8. Sun A Chu CT Wu YC Yuan JH. Mechanisms of depressed natural killer cell activity in recurrent aphthous ulcers Clin Immunol Immunopathol 1991 60 83 92
9. Hayrinen-Immonen R Nordstrom D Malmstrom M Hietanen J Konttinen YT. Immune-inflammatory cells in recurrent oral ulcers (ROU) Scand J Dent Res 1991 99 510 8
10. Hayrinen-Immonen R. Immune-activation in recurrent oral ulcers (ROU) Scand J Dent Res 1992 100 222 7
11. Sun A Chu CT Liu BY Wang JT Leu JS Chiang CP. Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers Proc Natl Sci Counc Repub China B 2000 24 116 22
12. Rogers RS Sans WM Shorter RG. Lymphocytotoxicity in aphthous stomatitis: lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Behcet syndrome Arch Dermatol 1974 109 361 3
13. Blackwell TS Christman JW. Sepsis and cytokines: current status Br J Anaesth 1996 77 110 7
14. Nohynek H Teppo AM Laine E Ieinonen M Eskola L. Serum tumor necrosis factor-α concentrations in children hospitalized for acute lower respiratory tract infection J Infect Dis 1991 163 1029 32
15. Wong GHW Golddel DV. Tumor necrosis factor-α and -β inhibit virus replication and synergize with interferons Nature 1986 323 819 22
16. Scuderi P Sternling KE Lam KS. Raised serum level of tumor necrosis factor in parasitic infection Lancet 1986 2 1364 5
17. Buno IJ Huff JC Weston WL Cook DT Brice SL. Elevated levels of interferon gamma, tumor necrosis factor α, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis Arch Dermatol 1998 134 827 31
18. Natah SS Hayrinen-Immonen R Hietanen J Malmstrom M Konttinen YT. Immunolocalization of tumor necrosis factor-α expression cells in recurrent aphthous ulcer lesions (RAU) J Oral Pathol Med 2000 29 19 25
19. Taylor LJ Bagg J Walker DM Peters TJ. Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration J Oral Pathol Med 1992 21 21 5
20. Ebersole JL. Cells and tissue of the immune system In Slots J Taubman MA eds Contemporary oral microbiology and immunology 1st edn St Louis, MO, USA Mosby 1992 83
21. Sun A Chia JS Chang YF Chiang CP. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations J Oral Pathol Med 2003 32 206 14
22. Sun A Chang YF Chia JS Chiang CP. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations J Oral Pathol Med 2004 33 133 9
23. Popovic M Stefanovic D Pejnovic N et al. Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis Transplant Proc 1998 30 4135 6
24. Lewinski U Mavligib G Hersh E. Cellular immune modulation after a single high dose of levamisole in patients with carcinoma Cancer 1980 46 2185 94
25. Janssen PA. The levamisole story Prog Drug Res 1976 20 347 83
26. Redondo JM Lopez-Guerrero JA Fresno M. Potentiation of interleukin-2 activity by levamisole and imidazole Immunol Lett 1978 4 31 41
27. Sun A Chiang CP Chiou PS Wang JT Liu BY Wu YC. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus J Oral Pathol Med 1994 23 172 7
28. Sugermann PB Savage NW Seymour GJ Walsh LJ. Is there a role for tumor necrosis factor-alpha (TNF-α) in oral lichen planus J Oral Pathol Med 1996 25 219 24